Reddit Posts
Mentions
Short, ATYR. Mid, CIFR. Long, BULL
GLXY - holding IXHL - holding KSS - holding RKT - buying ATYR - buying BYND - sold DNUT - sold
950k shares of ATYR. I own 1% of the company
I picked up a bit more ATYR when it dipped a couple of days ago. Pretty sure I'll always wish I'd gotten more. It's a good stock.
ATYR and ZETA if you like money
$75K in ATYR for 10x potential
Yall still not got your ATYR and CLOV?
The ATYR run has just started
I didn't. I made $5.6K on ATYR this morning near open and called it a day. I bought 4000 shares yesterday (7/22/2025) intraday at $5.47 and watched it drop to $5.25. Pissed, but didn't react. It jumped straight up on open and almost hit $7 per share. I got out at $6.88. That scenario doesn't happen enough. Looks like I would have made a much bigger killing in IXHL if I used the same amount of funds and exited.
This is no squeezing this man says ATYR is a lifestyle change. CountryDumb
ATYR, wild price targets. Phase 3 finalizing rn. Price target of $30c currently at 6 DYOR
ATYR, phase 3 trials incoming. Momentum building big time, still 1/5 of the price targets
ATYR up 30% today and that isn’t even close to what Q3 growth should be.
ATYR, phase III incoming in Q3. Wildly undervalued. Price targets average around $30 and the stock is at $6.
$ATYR 🚀 pump it and dump it!!! 200%gains incoming
Yesterday it sold off hard. It’s got a huge amount of shorts on it. If ATYR misses on the data, it’ll crash back to $1
ATYR moving serious today 😂
ATYR is the only thing worth squeezing. It’s real. Stage 3 trial completed this morning. Massive insider buy this morning prior. Stock popped to 13 for a millisecond. Today’s the day
ATYR has significant short interest. Just saying.
$ATYR so much room to run still. High risk, high reward - just how you regards like it
Didn’t expect ATYR to fly but it’s a good thing to wake up to
ATYR doesn’t need wsb … take a 👀
We can all re-tyr with ATYR
A very binary event is coming for ATYR
There’s a guy who does an in depth analysis on ATYR going through the options and all. I’ll try to find it later but essentially September onwards is possibly going to be massive.
Generational buying opportunity on ATYR. Phase 3 results come out any week now.
Whats your opinion on ATYR?
ATYR is the next OPEN 6x by September
Man, I love it! Sounds like you’ve got something figured out there, I’m 24 now and I deployed all my powder on ATYR which is not much but it’s what I had but scalping can be very exciting specially when you get to a level where you can do it with more volume and capital
ATYR bag holders what's the move?
ATYR bag holders do we hold or is this looking bad?
CHRS solid play based alone on their recent 8-k's, when you contrast it to the situation they were on the Q1 2025 Q-10. ATYR more of a binary play for phase 3 results, I think based on an adjusted NVP that they have great upside potential if there is aproval. IXHL is also on my radar, I may re-enter monday with some as I think there is some gas still there. Aside from that, I don't have more plays for now, I'd like to hear some ticker suggestions.
everyone rambling about ATYR.. but not about APYR... iykyk
For CHRS the catalyst is the Q2 ER on early August, for ATYR the phase 3 results, no specific date yet but they said around Q3 so probably july/august.
ATYR and CHRS my next main plays, I think they have interesting fundamentals and catalysts coming.
ATYR and CTM on my watchlist
Well, some tickers to check out for short/mid-term volatility if you are interested: CHRS, ATYR and OPTT. For now not invested, but those have caught my attention, probably will do a deeper DD on monday and then decide to enter or not.
ATYR has a better chance of go8ng much higher
I know nothing other than the fact that ATYR is gonna rip off faces
Exactly! Maximum pessimism + high short interest + catalyst = squeeze city. The dilution point is real, though. BUT with $250M cash and 2+ year runway, they'd have to be complete morons to dilute at $0.86. That's the beauty - the cash position basically removes dilution risk in the near term. ATYR ripping today is exactly the kind of action we could see. Biotech shorts are skittish AF right now. Once one starts running, they all get nervous. CHRS is basically a loaded spring. Might sit here for weeks doing nothing, then one random PR and boom - shorts scrambling for the exits. The "can't get any lower" thesis is my favourite setup. Worst case we're wrong and it stays at the same level
Okay got it now! It’s a squeeze-gamble. I really like the „can’t get any lower, must get up“-part. Unless that happens in the form of dilution ☠️ ATYR shorts got to squeezing today, maybe CHRS will do to!
ATYR on the move. 
$ATYR Biotech company with solid science, ongoing Phase 3 with readout in September. Their drug, efzofitimod, doesn’t have any competitor in the sarcoidosis curative treatment field. Already shown positive results in Phase 2. FDA is craving for it, emitted a statistical recommandation to ease the approval. Multi-billion market. Trading under 6$, that's a bargain. Targeting 20-35$ by November, 80-100$ in next years.
I bought ATYR stock yesterday. This stock is going to 20 bucks. Good luck.
For pennystock winnings I usually spread them out. I take some and put them in longer holds and then the rest I keep in the pennystock fund. With these winnings I added to my ATYR, and RKLB position, then some in CHRS. The rest I’m keeping idle as there isn’t anything short term that I’ve looked at that I need to gamble on.
What’s AI? ACHR ran from $3 to $11 on a short squeeze for a $2.1M gain. Then I bought more ATYR
Look I am invested in ATYR and I started buying in low at the beginning of this year. Their P3 readout will be this fall (before Halloween). It will be a make or break scenario. Other people bought the same stock even cheaper back in 2023, for the same readout in fall 2025. This is not a get rich quick scheme. It’s focus, determination and conviction.
I could suggest also the ATYR stock. It has a 80-85% POA rate and an easier way to get approved. Also there are some big names there that either speak of it or bought shares. Now it’s around 5,69 but its promised to grow to 35% Anyways you can research that yourself too. There are enough good posts about it here on reddit. Second one is KALV, but it might be a long term one, some say that if it breaks the 15,50$ it can grow to 30-35$ or ideally 50$. Currently its standing at 14.76$ it has already fallen after the earning calls by 10% but its slowly growing. I want to risk and go all in with the first one. And i am just keeping an eye in kalv. Not a financial advice.
just loaded up on some ATYR shares. Big catalyst coming up this Fall.
I just bought 350 shares at .56 this morning, I’m rubbing my belly in hopes we get lucky but mainly a win for the people that will benefit from this potential drug. So far I’m green with ATYR and still holding til October. You had me at long term investment also insider buying activity in June, might be something or a nothing burger.
So... currently my CSP targets are all things I either want to own at a cheaper price, or believe in long term. ASTS CRWV ATYR (probably will quit on these before EOY) I was selling ATM or well ITM on both ASTS and ATYR and they have printed. Now that ASTS has blasted off, I'm waiting for the price to settle a bit before I plow back into it again. ATYR should have some big trial news coming out in October, so I'm basically gearing up and prepping for that. Then I'll reevaluate.
ATYR have a product in phase 3 trials that if successful FDA approval will propel them up rapidly.
I just posted a biotech/ATYR piece on my blog r/CountryDumb. You might find it interesting. It’s got a couple of nuggets in there about the company
NFA- u/Dogton good luck to you sir, you need to stop shyte posting your "Mods Take Out The Trash" on multiple subs, and then deleting like you recently did about ATYR, $VCIG, etc... StockScan, Benzinga, TipRanks, MarketBeat, Yahoo Finance, [Public.com](http://Public.com), CoinCodex, WalletInvestor, TradingView, and Danelfin: Time Horizon Analyst Consensus High Estimate Low Estimate % Upside from $0.60 3 months $3.73 $3.89 $3.57 +521% 6 months $3.45 $3.53 $3.49 +475% 9 months $5.63 $7.07 $2.94 +839% 12 months $6.25 $14.00 $2.94 +939% # Notes: * **Consensus estimates** are based on a blend of analyst targets from StockScan, Benzinga, TipRanks, and other leading platforms, cross-referenced for consistency. * **The wide range** in 9- and 12-month targets reflects high uncertainty and volatility in the biotech sector. # Fundamental Analysis * **Financial Health:** CGTX has a high cash burn rate and limited revenue, which is a risk factor. Recent filings show ongoing concern about sustainability without additional capital. * **Pipeline:** The company is advancing zervimesine (CT1812) for Alzheimer’s and Dementia with Lewy Bodies, with a pivotal FDA meeting on July 9, 2025, and applications for breakthrough therapy designation. Positive regulatory outcomes could be a major catalyst. * This meeting was positive. * **Valuation:** The current price is deeply discounted relative to analyst targets, but this is largely speculative and contingent on clinical/regulatory success. # Technical Analysis * **Short-term technical** are bearish: * Most moving averages (5, 20, 50, 200-day) signal “Sell”. * Oscillators (RSI, CCI) are neutral to weak, indicating lack of momentum. * AI-powered technical models rate the stock as “Sell” for the next 3 months, with a low probability (36.2%) of outperforming the market. * **Longer-term technical** are inconclusive due to low trading volume and high volatility, but price targets suggest potential for outsized moves if fundamentals improve.
That has happened with $TARA and a numerous other biotechs. None of them have changed their names. I run a family office and a biotech centered fund. My interest here is simply because these single thesis heavy biotechs $SAVA, $INMB, $ATYR, etc are heavily manipulated by funds and insiders through social media feedback loops.
Saw your post about ATYR earlier this year. Been buying shares the past few months. Cannot wait for this to rip.
I’ve been eyeballing ATYR for a couple weeks now. I asked Gemini deep research to analyze it back then. Seems like there is quite the potential for asymmetrical returns here when phase 3 results are announced. Maybe tomorrow is the day I pull the trigger
If ya wanna try bio again, ATYR catalyst phase 3 results in September......
Join his group it’s gold. I bought 4k shares of ATYR thanks to this guy.
I too am waiting for a moonshot for ATYR